September 19, 2021
1 min read

US FDA panel backs booster shot for elderly, high risk groups

Members of the committee expressed doubts about the safety of a booster dose in younger adults and teens…Reports Asian Lite News

A Food and Drug Administration (FDA) advisory panel has endorsed a booster shot of the Pfizer-BioNTech Covid-19 vaccine six months after full inoculation in people above 65 years and for individuals at high risk for severe disease.

The decision late Friday came after members of the FDA’s Vaccines and Related Biological Products Advisory Committee voted against advising the agency to approve boosters for anyone 16 and older after hours of debate, reports Xinhua news agency.

Members of the committee expressed doubts about the safety of a booster dose in younger adults and teens, and said they wanted to see more data about the safety and long term efficacy of a booster dose.

A decision about boosters from the FDA is expected in the next few days.

Meanwhile, another advisory panel of the Centers for Disease Control and Prevention (CDC) is also scheduled to meet next week on how to apply the FDA’s eventual decision and can fine-tune the recommendation.

President Joe Biden’s administration have recently announced a plan to begin administering booster doses to the general population during the week of September 20, pending sign-offs from the FDA and CDC.

The CDC published data on Friday showing that all three Covid-19 vaccines available in the US — Pfizer-BioNTech, Moderna and Johnson & Johnson — still provide strong protection against hospitalisation.

Moderna’s vaccine provided 93 per cent protection against hospitalisation, Pfizer’s was 88 per cent and Johnson & Johnson’s Janssen vaccine was 71 per cent, said the CDC study.

ALSO READ: Pakistan ‘surprised’ by Blinken’s remarks on reassessing ties

Previous Story

Imran Khan rues decision of Pak siding with US

Next Story

‘A new chapter in Iran-Tajikistan ties’

Latest from -Top News

India Tightens Checks on Chinese Imports

India has ramped up monitoring of Chinese imports amid growing concerns of cheap goods being redirected into the Indian market following the United States’ steep tariff hike on Chinese exports. Commerce Secretary

Economists Warn of Impending US Recession

Leading global brokerages and economists are sounding alarm bells over the likelihood of a US recession, following the Donald Trump administration’s announcement of sweeping reciprocal tariffs on foreign imports. JPMorgan Chase &

Trump tariffs send world markets into panic

US benchmark crude oil shed $2.70 to $64.25 a barrel after major oil producers announced they plan to increase production. Brent crude, the international standard, was down $2.63 at $67.51 a barrel
Go toTop

Don't Miss

‘Reprehensible’: US on Kyiv drone attacks

Ukraine’s capital city Kyiv was rocked by multiple explosions early

What India can learn from US antitrust bill?

The current draft is limited to online platforms with at